SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is attracting attention following a strong earnings report that highlighted significant year-over-year revenue growth and a substantial expansion in its order backlog. While some traders express frustration regarding the company's recent share offerings and insider activity, many are focused on the long-term potential of the firm's role in the power infrastructure buildout for AI data centers.

Vera Therapeutics, Inc. is a clinical stage biotechnical company, which engages in the development and commercialization of transformative treatments for immunological diseases. Its product includes the TRUTAKNA injection. The company was founded by Marshall W. Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is currently the focus of market attention as investors anticipate upcoming Phase 3 ORIGIN 3 clinical data for its IgA nephropathy treatment, with many pointing to a high short interest and potential buyout interest as catalysts for a significant move. The community remains largely bullish, emphasizing the asset's clinical promise and institutional backing while awaiting the data release by the end of the third quarter.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending following the introduction of a new high-efficiency solar cell, with the community debating the company's valuation, potential growth from the upcoming Iridium acquisition, and continued concerns regarding the Neutron rocket development timeline. While some traders are bullish on the company's long-term end-to-end space strategy, others remain skeptical, citing share dilution and macroeconomic pressures.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The index is trending amid volatility driven by conflicting signals regarding AI development, rising Treasury yields, and uncertainty ahead of the Federal Reserve's upcoming rate decision. Traders are reacting to aggressive intraday price swings, with significant disagreement between those anticipating further declines due to inflationary pressures and those betting on a continued recovery.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is trending as shares rally following the Roblox Developers Conference (RDC), where the company outlined new initiatives for game discovery and creator tools. While some traders express optimism regarding the company's growth inflection and strategic focus, others remain skeptical, debating the long-term impact of its platform changes and valuation.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending as traders speculate on its upcoming merger with Agility Robotics, a company gaining attention for its commercial humanoid robotics technology and strategic backing from major tech firms. Investors are showing strong interest in the stock as a pure-play humanoid robotics exposure, with discussions highlighting institutional accumulation and the anticipation of new options trading.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently under downward pressure due to a combination of persistent insider selling and broad sector volatility linked to AI and data center infrastructure concerns. While some traders are highlighting the stock's significant long-term growth potential and large-scale data center contracts as a basis for a bullish outlook, others express frustration over recent price underperformance and market sentiment regarding AI development.

Oracle Corporation. The Group's principal activities are to develop, manufacture, market, distribute and service computer software. It has two businesses, software and services, which are further divided into five segments. Its software business consist of two segments: The new software license segment is engaged in the licensing of database, middleware software and applications software.The software license updates and product support segment provides customers with rights to unspecified software product upgrades and maintenance releases, internet access to technical content, internet and telephone access to technical support personnel. Its services business is comprised of three segments: The consulting segment provides services in business strategy and analysis, business process simplification, solutions integration and the implementation, enhancement and upgrade of database, middleware and applications software. On Demand includes Oracle On Demand and Advanced Customer Services.

Oracle Corp.

Oracle is trending following reports of a fresh round of job cuts alongside sustained multi-billion dollar capital expenditures for AI infrastructure. Traders are debating whether these workforce reductions signal improved operational efficiency and long-term bullishness or indicate an underlying slowdown in AI-related momentum.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is trending as traders focus on the Federal Reserve's upcoming policy meeting, with a significant majority anticipating a rate hike amid persistent inflation concerns. The community remains divided between those expecting potential volatility from higher bond yields and those speculating that the central bank may keep rates unchanged.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates following the company's recent healthcare conference participation and anticipation of upcoming Phase 2 NSCLC trial data. While the stock has seen significant momentum, community sentiment remains focused on institutional accumulation and the expectation that the company's solid tumor platform and clinical milestones will drive long-term value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Feed

News

Sentiment

Info

Historical Prices

STHYPE Staked HYPE

Fundamentals

Latest STHYPE News